Newsletter signup

Sign up to receive our free quarterly newsletter!

Subscribe Today!
Did you know... To me, old age is always fifteen years older than I am.
Source: Bernard M. Baruch


Fuqua Center Video

In May of 2015, the Fuqua Center for Late-Life Depression and the Geriatric Outpatient Clinic moved to 12 Executive Park Drive, N.E., 5th Floor, Atlanta, Georgia 30329 as part of the Emory Brain Health Center.  Click on the following link to learn more about the Brain Health Center and to watch a video about the work of the Fuqua Center

WAGA-TV Feature on Treatment Resistant Depression,

February 20, 2017  Click Here for link to WAGA-TV report on Treatment Resistant Depression, ECT, and an interview with Dr. William McDonald, M.D., J.B.. Fuqua Chair for Late-Life Psychiatry, Emory University School of Medicine.

Tom Johnson: I Suffer from Depression

Click here to watch this powerful video of one man's struggle with depression and his climb out of the darkness.  "I was relieved to learn what it was that was taking me in to this darkness........with medication and talk therapy..... I came up and out".   (NOTE:  Tom Johnson is a well known journalist who once served as the publisher of the Los Angeles Times and later became the President of CNN.  He believes that "you are more than a are more than a position")

US Antidepressant Use Increasing, Data Indicate.

 NBC Nightly News (8/15, story 8, 0:30, Holt) reported, “New numbers out from the CDC show about one in eight Americans over age 12 reports taking antidepressants.” According to TIME (8/15, Sifferlin), the report from the National Center for Health Statistics indicates “that from 2011 through 2014, the most recent data available,” nearly “13% of people 12 and older said they took an antidepressant in the last month.” This “number is up from 11% in 2005-2008.” Medscape (8/15, Brooks) reports, “For the period 2011-2014, women were about twice as likely as men to report past-month antidepressant medication use (16.5% vs 8.6%).” Meanwhile, “Overall, antidepressant use increased with age, from 3.4% among people aged 12 to 19 years to 19.1% among those aged 60 years and older.” Medscape adds, “Increased use with age occurred in both men and women.” HealthDay (8/15, Mundell) also covers the story. (SOURCE: APA Headlines)

Transcranial Magnetic Stimulation May Differentiate Alzheimer’s Disease From Frontotemporal Dementia, Small Study Suggests.

 Medscape (8/15, Anderson) reports that a study “transcranial magnetic stimulation (TMS) may differentiate Alzheimer’s disease (AD) from frontotemporal dementia (FTD) with a high degree of diagnostic accuracy.” Medscape points out that “the analysis included 79 patients diagnosed with AD...and 61 patients diagnosed with FTD,” as well as 32 healthy controls. The findings were published July 26 in Neurology. (Source: APA Headlines)

US News & World Report Contributor Discusses How To Safely Stop Using Antidepressants

 U.S. News & World Report (8/15, Levine) contributor David Levine discusses how to safely stop using antidepressants. Levine writes that “deciding to go off antidepressants ‘should be considered thoughtfully and made with the support of your physician or therapist to make sure you’re not stopping prematurely,’ according to Harvard Health Publications, from Harvard Medical School.” However, “There may in fact be no need to stop.” Dr. Anita Everett, president of the American Psychiatric Association, said, “People have been on antidepressants for 20 or 30 years, with no evidence of any harm.” (SOURCE: APA Headlines)

Researchers Are Trying To Better Understand The Connection Between Obesity And Depression.

 Kaiser Health News (8/11, Luthra) reported researchers are trying to better understand the “bidirectional” connection between obesity and depression, because both conditions are becoming more common. Anita Everett, the president of the American Psychiatric Association, said, “It’s not a one-shot thing. Both of these are chronic conditions. They don’t lend themselves to episodic treatment. It’s not like you take a course of treatment to [make it] go away.” (SOURCE: APA Headlines)

Hormone Klotho May Improve Cognitive Performance In Brains Damaged By Dementia, Mouse Study Suggests.

 The Los Angeles Times (8/9, Healy) reports a study (8/8) published Tuesday in the journal Cell Reports showed the administration of hormone klotho, in the Times’ words, “improved the cognitive performance and even the mobilit(y of mice whose brains were riddled with clumps and tangles of toxic proteins that are hallmarks of dementia and other debilitating brain diseases.” Researchers said the study showed “amazing and remarkable” results, adding that the impact of klotho administration was immediate among younger mice. (SOURCE: APA Headlines)

Association Between Obesity, Depression Explored.

 Politico (8/9, Luthra) explores the association between obesity and depression, suggesting that it might be advantageous to treat both conditions together. According to the article, the American Medical Association “dubbed” obesity “a ‘disease’ four years ago, and the ACA limited cost sharing for some preventive obesity treatments.” But, it could be difficult to find “a physician able to address both” obesity and depression at the same time. Anita Everett, president of the American Psychiatric Association and an assistant professor of psychiatry at the Johns Hopkins Bloomberg School of Public Health, said, “It’s not a one-shot thing. Both of these are chronic conditions. They don’t lend themselves to episodic treatment.” In any case, “research suggests primary care physicians...aren’t meeting clinical standards for treating depression,” while “most psychiatrists aren’t trained in weight management.” (SOURCE: APA Headlines)

Stroke Risk Declining For Men But Not For Women

 ABC World News Tonight (8/9, story 12, 0:20, Muir) reported a new study found that “fewer men are suffering strokes in the US while the number of women having strokes remains the same.” The CBS Evening News (8/9, story 9, 2:10, Mason) calls the findings “a puzzling and concerning trend.” Dr. Kathryn Rexrode from Brigham and Women’s Hospital suggested, in CBS’s words, “risk factors for stroke, such as obesity, high blood pressure, an irregular heartbeat and diabetes may for some reason affect women differently than men.” The New York Times (8/9, Bakalar, Subscription Publication) reports the study, published in Neurology, found that, adjusted for age and race, “stroke incidence in men had decreased to 192 per hundred thousand men in 2010, down from 263 in 1993–94. But for women the incidence was 198 per hundred thousand in 2010, down from 217 in 1993–94, a statistically insignificant change.” Dr. Tracy E. Madsen, an assistant professor of emergency medicine at Brown University, said, “Maybe we’re not controlling risk factors to the same extent in women. Or maybe there’s a biological difference in the way these risk factors cause strokes in men versus women.” HealthDay (8/9, Reinberg) reports Madsen, the lead researcher, said, “We also found that the declining rates of stroke in men are primarily driven by a decrease in ischemic strokes, a specific type of stroke caused by a lack of blood flow to the brain as a result of blocked arteries or clots.” In contrast, rates for hemorrhagic stroke “remained stable for both women and men, the study found.” On its website, ABC News (8/9, Nosova) reports, “Common stroke risk factors, such as high blood pressure, high cholesterol and diabetes, are all on the rise – a finding that likely reflects an aging population overall.” Also covering this story are Healio (8/9, Miller) and Medical Daily (8/9, Delzo). 

Advances in Pharmacogenomics May Help Individualize, Tailor Medication Treatment For Depression

 NBC Nightly News (8/7, story 9, 2:10, Holt) reported that in “a medical advancement that could bring hope to the 15 million Americans who suffer from depression,” researchers working “at the cutting edge of” pharmacogenomics are now “looking at how genetics influence the way we process medications.” This is an effort to help individualize and tailor antidepressant treatment to individuals without having them go through “excruciating trial and error” to find the most effective medication. The NBC News (8/7, Charles, Dunn) website also covers the story.(SOURCE: APAHeadlines) 

Study Suggests Blood Pressure Fluctuations Linked To Dementia

 Reuters (8/7, Rapaport) reports a study of 1,674 older adults published in Circulation found that “people with the most variations in blood pressure,” which was measured through a month of home blood pressure readings, “were more than twice as likely to develop dementia” within the next five years. While the study didn’t address causation, lead study author Dr. Tomoyuki Ohara, of the Graduate School of Medical Sciences at Kyushu University in Fukuoka City, said, in Reuters’ words, “it’s possible that daily variation in blood pressure might cause changes in the brain’s structure and function that contribute to the development of dementia.” Dr. Costantino Iadecola, director of the Feil Family Brain and Mind Research Institute at Weill Cornell Medicine in New York wrote in an accompanying editorial that, in Reuters’ words, “fluctuations in blood pressure could be a symptom of cognitive decline in progress rather than a risk factor for developing dementia in the future.” (SOURCE: APA Headlines)

Middle-Aged People With Risk Factors For Heart Attacks, Stroke May Be More Likely To Develop Dementia In Old Age, Researchers Say.

 Reuters (8/7, Rapaport) reports, “Middle-aged people with risk factors for heart attacks and stroke may be more likely to develop dementia in old age than people with healthy cardiovascular systems,” researchers concluded. The study revealed that smoking, diabetes, hypertension, and prehypertension were associated with “higher odds of dementia.” (SOURCE: APA Headlines)

Elderly Patients Who Experience Postoperative Delirium May Be More Likely To Suffer From Lifelong Cognitive Impairment Or Dementia, Research Suggests.

 Medical Daily (8/1, Delzo) reports that elderly “patients who experienced postoperative delirium were three times more likely to suffer from lifelong cognitive impairment or dementia,” researchers concluded. The findings of the 1,152-patient study were published online June 28 in the British Journal of Anesthesia.(SOURCE: APA Headlines)

People Born In States With High Stroke Mortality Rates May Have Greater Risk For Dementia, Research Indicates

 Reuters (7/31, Rapaport) reports that being born in “the so-called stroke belt, a band of southern US states with high stroke mortality rates, is associated with increased odds of developing dementia, even for people who relocate,” researchers found after examining data on some “7,423 adults living in Northern California, including 1,166 people born in high stroke-mortality states – all but one in the South: Alabama, Alaska, Arkansas, Louisiana, Mississippi, Oklahoma, Tennessee, South Carolina and West Virginia.” The findings were published online July 31 in JAMA Neurology. (SOURCE: APA Headlines)

Men Who Consume More than 67 Grams Of Sugar Per Day May Increase Their Risk Of Mood Disorders, Research Suggests

 The Telegraph (UK) (7/27, Reporters) reports that “men who consumed more than 67 grams of sugar per day increased their risk of mood disorders by more than a fifth compared with those with an intake of less than 39.5 grams.” Researchers arrived at this conclusion after comparing “sugar consumption...with rates of common mental disorders in more than 5,000 men and 2,000 women between 1983 and 2013.” Interestingly, the study revealed “no link between sugar intake and new mood disorders in women.” The findings were published online in Scientific Reports. (SOURCE: APA Headlines)

Ketamine Promising As Depression Treatment, Researchers Say.

 TIME (7/27, Oaklander) reports on the prospects for ketamine to be a therapy for depression. Dr. Carlos Zarate, chief of the “experimental therapeutics and pathophysiology branch at the National Institute of Mental Health and one of the foremost researchers of ketamine,” said, “It’s been a paradigm shift, that now we can achieve rapid antidepressant effects. Now we know there’s something radically different.” But, “a task force from the American Psychiatric Association (APA) concluded in an issue of the medical journal JAMA Psychiatry that ketamine wasn’t ready to be widely used as a medication for treatment-resistant depression.” (SOURCE: APA Headlines)

Transcranial Magnetic Stimulation May Help Distinguish Alzheimer’s From FTD, Small Study Indicates.

 HealthDay (7/26, Preidt) reports, “Distinguishing Alzheimer’s disease from” frontotemporal dementia (FTD) “may get easier using a new, noninvasive technique,” researchers found after testing “a technology called transcranial magnetic stimulation in 79 people with probable Alzheimer’s disease, 61 people with probable FTD, and 32 people of the same age with no signs of dementia.” The findings were published online July 26 in Neurology. (SOURCE: APA Headlines)

Practicing Healthy Eating Habits May Improve Cognitive Function, Reduce Risk For Dementia Later In Life, Studies Suggest.

 Healio (7/26, Demko) reports, “Practicing healthy eating habits can improve cognitive function and reduce the risk for dementia later in life,” researchers concluded after examining “data from four large population-based studies.” One study involved examination of the “connection between inflammation-related nutrient pattern...and cognitive function and structural MRI findings in the brain using data on 330 elderly adults without dementia.” The findings of all four studies were presented recently at the Alzheimer’s Association International Conference. (SOURCE: APA Headlines)

Depression That Starts Early In Life May Increase Risk For Alzheimer’s, Research Suggests

 Medscape (7/24, Anderson) reports, “Depression that starts early in life increases the risk for Alzheimer’s disease,” researchers concluded after examining “data from the Prospective Population Study of Women in Gothenburg Sweden, which began almost 50 years ago.” Included in the study sample were some “800 women (mean age, 46 years), born between 1914 and 1930.” The findings were presented at the Alzheimer’s Association International Conference 2017.(SOURCE: APA Headlines)

Heart Attack Sufferers Are More Likely To Suffer Major Depression.

 Kaiser Health News (7/20, Szabo) reports that people who are “hospitalized for heart attack or chest pain” are approximately “four times” more likely to “develop major depression” than the general population, according to the American Heart Association. The article adds that more health systems are trying “collaborative care,” where “care managers” work with primary care physicians to address physical and mental health conditions together. The article quotes Dr. Anita Everett, president of the American Psychiatric Association, as praising care managers for their ability to reach out to patients and not allow them to “stay at home and get depressed.” (SOURCE: APA Headlines)

Nearly One-Third Of Dementia Cases Preventable Based On Lifestyle Factors, Report Finds.

 The Washington Post (7/20, Bahrampour) reports a study presented on Thursday at the Alzheimer’s Association International Conference in London found that nearly one-third of the world’s dementia cases are preventable through managing “factors such as education, hypertension, diet, hearing loss and depression over the course of a person’s lifetime.” Researchers found that controlling the factors could reduce one’s risk of developing dementia by 35 percent.Reuters (7/20, Kelland) reports the “wide-ranging analysis” detected nine “particularly important” risk factors, namely “staying in education beyond age 15, reducing high blood pressure, obesity and hearing loss in mid-life, and reducing smoking, depression, physical inactivity, social isolation and diabetes in later life.” (SOURCE: APA Headlines)

US Researchers Planning Comprehensive Study To Examine Effects Of Lifestyle Changes In Preventing Dementia

 In “Science Now,” the Los Angeles Times (7/19, Healy) reports “researchers across the United States” are planning “an ambitious clinical trial” of 2,500 Americans to see if “a comprehensive health and lifestyle makeover” can “prevent or delay cognitive impairment.” According to the Times, a similar strategy showed “improve[d] cognitive aging in a group of Finns at elevated risk of dementia.” The “planned $20-million study,” which was “announced Wednesday at the Alzheimer’s Assn.’s International Conference in London,” would start “recruiting participants in 2018.” (SOURCE: APA Headlines)

Women Who Experience First Menstruation Earlier May Have An Increased Depression Rate Later In Life, Study Indicates.

 Medical Daily (7/19) reports that “women who experienced their first menstruation earlier, and therefore were exposed to the hormone estradiol for longer, had a decreased depression rate later in life.” The study, which “was based on the medical history of more than 1,300 regularly menstruating and premenopausal women aged 42 to 52 at the start of the study,” suggests that “differences in exposure to estradiol, a derivative of estrogen, as well as long-term use of birth control, may both explain why some women experience significant signs of depression around the time they go through menopause and others are protected.” The findings were published online July 17 in the journal Menopause. (SOURCE: APA Headlines)

PET Scan Results Show Many Patients With MCI, Dementia May Not Have Alzheimer’s-Associated Plaques.

 The Washington Post (7/19, Bahrampour) reports researchers from the University of California, San Francisco Memory and Aging Center found among Medicare beneficiaries, only 54.3 percent of patients with mild cognitive impairment and 70.5 percent of those with dementia were found to have amyloid plaques present in their brains.The AP (7/19, Neergaard) reports that PET scans “may lead to treatment changes for a surprising number of patients whose memory problems are hard to pin down.” (SOURCE: APA Headlines)

Personalized Risk Estimate May Help Predict Which Individuals With Subjective Cognitive Decline Will Progress To Dementia

 MedPage Today (7/16, Fiore) reports that “a biomarker-based personalized risk estimate may help predict which patients with subjective cognitive decline (SCD) will progress to dementia.” researchers found that the “model that takes into account age, Mini Mental State Exam (MMSE) scores, MRI brain volume, and cerebrospinal fluid (CSF) biomarkers had good prognostic performance (C-statistic of 0.82) in a cohort of patients who visited a memory clinic in the Netherlands.” The findings of the 481-patient study were presented at the Alzheimer’s Association International Conference. (SOURCE: APA Headlines)

Ketamine May Reduce Active Suicidal Thoughts in Patients With Treatment-Resistant Depression

 Ketamine may be able to rapidly reduce persistent suicidal thoughts in medicated patients with treatment-resistant depression, according to a small study published online in the Journal of Clinical Psychiatry. The findings suggest that ketamine may offer an alternative for stabilizing people in emergency situations. Previous work has shown that ketamine can provide rapid relief of depressive symptoms and lower suicidal ideation scores in patients with both unipolar and bipolar depression. This study is the first to exclusively enroll patients with active suicidal ideation (a score of 3 or higher on the Columbia Suicide Severity Rating Scale). Fourteen patients with major depressive disorder recruited for the presence of current, stable (three months or more) suicidal thoughts received open-label ketamine infusions over three weeks (0.5 mg/kg over 45 minutes for the first three infusions; 0.75 mg/kg over 45 minutes for the last three). All the patients were taking antidepressants at a dose that was stable for at least 4 weeks prior to enrollment. Explicit suicidal ideation scores (using scales such as the C-SSRS) and implicit scores (using the Implicit Association Test which measures overall attitudes and beliefs) were assessed four hours after each infusion.As Dawn Ionescu, M.D., and colleagues reported, there was a consistent decrease in suicidal scores during the three week acute phase, with seven of the 14 patients achieving remission of their ideation (a C-SSRS score of 0) by the final infusion; during a naturalistic follow-up three months later, two of these seven patients were still free of suicidal thoughts. In addition, IAT scores went up, suggesting a more positive outlook on life.“Given the length (three months or more) of participants’ ongoing suicidal ideation and the lack of currently available antisuicidal agents, this steady decrease in suicidal ideation within three weeks is noteworthy,” the authors wrote.Because there were no control groups, the authors could not be sure if multiple infusions were providing any more benefit than a single infusion, nor could they rule out that ketamine was only augmenting antidepressant action rather than acting on its own. They concluded, “Larger controlled studies (including more serious/acute patients in the emergency room) are necessary to study ketamine’s antisuicidal effects and the relationship between antisuicidal and antidepressant effects.For related information, see the American Journal of Psychiatry article “Ketamine and Other NMDA Antagonists: Early Clinical Trials and Possible Mechanisms in Depression” and the Psychiatric News article “APA Task Force to Address ‘What’s Next?’ for Ketamine.” (SOURCE: APA Alert May 13, 2016)

Emory Magazine, Autumn 2015

Click here to read about the work being done by Emory researchers as they seek ways to help make the lives of those who are living longer better.  Page 24 includes information about the work being done by Dr. William M. McDonald, J.B. Fuqua Chair for Lte-Life Depression, whose research specializes in neuro-modulation therapies for elderly patients.

Charlee Lambert, a vibrant and active 92 year old, talks with William M. McDonald, MD, J.B. Fuqua Chair for Late-Life Depression and Professor of Psychiatry and Behavioral Sciences at Emory University

When Charlee, as she likes to be called, found herself divorced in her 60s after being a corporate wife and mother to six (6) children,  she asked herself, “is this all there is?” and decided to “make an end run” reinventing herself as a playwright and storyteller.  “It was a hard time of life ….telling my story got rid of a lot of things that were negative.”   To help support herself, she opened her home to boarders, something she continues to this day although now she does it as a way to stay active and around people.   “I’ve got 4 men living with me” she chuckles and credits them with her being sure to “comb my hair before coming out of my room each day.” Charlee says the keys to aging well include “being engaged, live your life with passion, and don’t let age get in the way.”  Her three (3) prong prescription for aging,   (1) stay adaptable, (2) have friends of all ages, and (3) have fun, have served her well.  Click here to watch the video 
NOTE:  Charlee Lambert died on November 4, 2015, a little over 10 months after this video was recorded. After watching the video, Charlee sent us the the following email: "I thought you did a great job on the video.  Lots of people have seen it and my family loves it.  i feel like I have been to my own Memorial Service."  Charlee touched many people with her engaging smile and enjoyable stories and lived life following her motto of aging gracefully.

5 Powerful Benefits to Pro-Aging Thinking

CNN January 6, 2015  "The way you perceive aging can actually influence how you age. Aging, like many aspects of life, is a self-fulfilling prophecy. Positive and negative attitudes can affect your health behaviorally, psychologically and even biologically. Being "pro-aging," or satisfied with your own aging, can make you adopt healthier behaviors, feel in control of how you age and even heighten your immune system. Being "anti-aging," or perceiving aging negatively, can do the opposite."  Click Here to Read the Artcile in Full

Helen Mayberg Delivers the Distinguished Faculty Lecture on "Rethinking Depression and its Treatment: Insights from Studies of Deep Brain Stimulation,"

 On Tuesday, February 4, 2014, Dr. Helen Mayberg delivered the Distinguished Faculty Lecture on "Rethinking Depression and its Treatment: Insights from Studies of Deep Brain Stimulation," sponsored by the Emory University Faculty Council. Mayberg is professor of psychiatry, neurology, and radiology, and holds the Dorothy C. Fuqua Chair in Psychiatric Neuroimaging and Therapeutics.  Click here for a link to the lecture.

Treating Depression with Electroconvulsive Therapy (ECT)

 Electroconvulsive Therapy (ECT) is an effective treatment for severe depression.  Click on the following links to watch a video on ECT from the January 25, 2012 episode of "The Dr. Oz Show".

Community Gardens: Where Seniors Cultivate Food and Friendships

Click on the following link to read how community gardens in Athens, Georgia are helping older adults in the area sustain good mental and physical 

The New York Times’s, Jane Brody Explores “Staying Independent in Old Age, With a Little Help

 In this fascinating article on remaining in one’s home as long as possible, Elinor Ginzler, director of the Cahnmann Center for Supportive Services at the Jewish Council for the Aging in Rockville, Md., writes that “the ability to age in place is greatly determined by the physical design and accessibility of a home, as well as community features like the availability of nearby services and amenities, affordable housing and transportation options.” Read the full article here.

Skydiving at 82

Click Here to watch the incredible story of 82 year old sky diver Dilys Price.

Link to NPR Article - 8 Ways You Can Survive - And Thrive In - Midlife

 Click Here for a link to an article from NPR outlining secrets to midlife happiness

Georgia Psychiatric Physicians Association Honors J. Rex Fuqua with the Distinguished Service Award at their 2011 Summer CME Meeting

 J. Rex Fuqua was recognized by the Georgia Psychiatric Physicians Association at the 2011 Summer CME Meeting for his outstanding efforts to positively impact the mental health of Georgians through the "Common Ground" initiative.

 J. Rex Fuqua is a businessman who understands community service and mental health.  Rex is an accomplished entrepreneur and Chairman and CEO of Fuqua Capital Corporation.  He has been extraordinarily successful in business, but to his community he is known as a leader in mental health.  Rex has been a determined advocate for the mentally ill in Georgia and nationally for two decades.  He has provided both leadership and a vision in developing novel treatments particularly in children and adolescents and promoting legislation to provide a safety net for patients with severe and persistent mental illness.

In Georgia, Rex funded W. Edward Craighead as the first J. Rex Fuqua Professor at Emory University.  Dr. Craighead started the Childhood and Adolescent Mood Disorders Program to provide therapy to children at risk for recurrent mood disorders.  He has also developed international research with investigators in Reykjavik, Iceland to understand the genesis of childhood mood disorders in the areas of psychological, genetic, environmental and neurobiological components of mood disorders. 

Rex has also been a guiding force on the boards of both the Fuqua Center for Late-Life Depression and Skyland Trail and his service on these boards is a level of his commitment to the mental health of Georgians of all ages and a testament to his leadership.  He is also a member of the Board of Councilors at Emory University's Carter Center and in that role has promoted legislation to provide for the most disadvantaged patients with mental illness.

On a national level, Rex has convened international experts to Skyland Trail to develop guidelines for the treatment of the severe and persistently mentally ill.  He has also been a leader in the National Network of Depression Centers, a network of leading depression centers and academic medical centers, and gave one of the keynote addresses at their recent national conference.

Rex is a trustee emeritus of Duke University, a member of the Board of Visitors of The Fuqua School of Business. He is a trustee and former chairman of the Atlanta Botanical Garden. He serves on the Board of the George West Mental Health Foundation and the Sheridan Arts Foundation. He is an emeritus member of the Board of Overseers of the Terry College of Business at the University of Georgia.


 One in four people over the age of 65 suffers from depression, yet often they don’t realize what is wrong.  Symptoms of depression in older adults are frequently attributed to memory problems or the aging process.  The mission of Emory's Fuqua Center for Late-Life Depression is to help people understand that depression is NOT a normal part of aging.  Click here to read more.

Click on the link to read about MEDCottage, a backyard living structure for an aging relative


Cobb Senior Services, in a monthly broadcast of Senior Focus, features issues faced by older adults. Featured in March are: Dr. Monica Parker and Eve Byrd. The program airs on Cobb's Government Access Chanel 23: Fridays-6 pm, Sat & Sun-1:30 pm, Mon-Noon.         

WATCH THE VIDEO: You may also see the informative discussion by clicking this link.

OLDER AMERICANS BEHAVIORAL HEALTH: Issue Brief 2: Alcohol Misuse and Abuse Prevention

Alcohol use problems in the older adult population often go unrecognized. Click on the following link to read more about this issue.

Men Recovering From Hip Surgery May Experience More Cognitive Difficulties, Higher Mortality Within First 22 Days Compared With Women, Study Suggests

 MedPage Today (2/8, Bachert) reports that research indicated “men who were recovering from hip surgery often experienced more cognitive difficulties and higher mortality within the first 22 days compared with women.” The study, which included 166 men and 168 women, was published in the Journal of the American Geriatrics Society.(SOURCE: APA Headlines)

Rapid Increase in Opioid Dose Increases Risk of New-Onset Depression

Click Here for Link to Article

Postmenopausal Anxiety Linked to Severe Impairment in Quality of Life

Click Here for Link to Article (SOURCE: Psychiatry Advisor)

Depression Often Untreated in Dialysis Patients

 Click Here for Link to Psychiatry Advisor Article

Aging In Place Poses Challenges For Many US Seniors.

 On its front page, the Wall Street Journal (9/26, A1, Levitz, Subscription Publication) reported in a 2,100-word article on the difficulties faced by many US seniors who choose to age in place in their own homes because they want to or simply cannot afford nursing homes or assisted living options. Aging in place is often difficult for seniors without families or friends, who live in places with a scarcity of supportive services to help them manage their day-to-day needs, and who have limited incomes. Meanwhile, on the front of its New York section, the New York Times (9/27, MB1, Leland, Subscription Publication) reported in a 2,470-word piece that last year, researchers at the “RAND Corporation estimated...that Americans spend 30 billion hours annually caring for older relatives and friends, with most of them juggling caregiving along with jobs, families and other demands on their time.” Seniors over the age of 85 are “among the fastest-growing age groups” in New York City, where “pressures” on family caregivers “have grown accordingly,” along with “higher rates of depression, stress, high blood pressure and heart disease. (SOURCE: APA Headlines)

Brain Activity Lowers Rate of Age-Related Mental Decline

 Click Here to Read Article in Psychiatry Advisor


Get Informed

  • Check out these helpful Documents
  • Find support or events through our Calendar
  • Visit our News section for articles

Get Involved